Standout Papers

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, ... 2008 2026 2014 2020 526
  1. Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies (2008)
    Raanan Berger, Rinat Rotem‐Yehudar et al. Clinical Cancer Research

Immediate Impact

19 by Nobel laureates 27 from Science/Nature 84 standout
Sub-graph 1 of 21

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Tertiary lymphoid structures in cancer
2022 StandoutScience
2 intermediate papers

Works of Abraham Kneller being referenced

Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
2008 Standout

Author Peers

Author Last Decade Papers Cites
Abraham Kneller 149 453 70 368 12 647
Colin Phipps 343 332 57 243 17 525
Hilary K. Hargreaves 254 199 109 213 15 684
Finlay MacDougall 363 348 159 298 13 665
Deborah B. Aquino 214 162 142 210 9 635
Elaine Murray 183 193 149 193 11 686
Therese White 226 191 168 170 21 546
TW Mak 290 197 198 292 13 668
KC Anderson 165 264 110 194 15 690
Daniel Couriel 131 198 89 299 20 654
M. Qazilbash 97 253 81 181 22 594

All Works

Loading papers...

Rankless by CCL
2026